Skip to content

Addressing Critical Issues and Therapeutics Emerging in Transplantation for COVID-19 (TREAT-COVID)

HSCT | Transplant

Transplant recipients are at high risk of severe COVID-19 outcomes. For transplant recipients surviving COVID-19 and/or experiencing the extreme stress associated with the pandemic was not only hard on them but their caregivers as well. Adults with organ transplants are generally excluded from studies because they do not easily fit into standardized protocols used for other high-risk groups. How the pandemic has affected transplant patients and their family physically, mentally and economically has not been investigated. This project will provide the actionable knowledge needed by policymakers to create clinical guidelines, and to support transplant patients and their families.

null

Conditions de participation

  • Sexe:

    Any

  • Âges admissibles:

    0 and up

Critères de participation

Inclusion Criteria:
Inclusion Criteria for Adult SOT Recipients or Caregiver:● Organ transplant recipient on at least one immunosuppressive (all genders) or their caregiver
● Followed by one of the participating transplant centers (or associated to someone on the study)
● Age ≥ 18 ● Able to provide informed consent
Inclusion Criteria for Pediatric SOT Recipient:● Organ transplant recipient on at least one immunosuppressive (all genders)
● Age <18 years ● Can be followed by one of the participating transplant centers
● Must have a family and/caregiver enrolled
Exclusion Criteria:
N/A

Lieu de l'étude

University of Alberta
University of Alberta
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Kim, Heather or Chelsea

[email protected]
17804076945
Étude parrainée par
University of Alberta
Participants recherchés
Plus d'informations
ID de l'étude: Pro00131530